Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 8, 2012, Pages 947-955

  Chandler, Wells M ^a   Rowe, Leslie R ^b   Florell, Scott R ^c   Jahromi, Mona S ^d   Schiffman, Joshua D ^d   South, Sarah T ^e  

^a Dominion   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; CHILD; COHORT ANALYSIS; CONFERENCE PAPER; DNA MICROARRAY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETICS; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; MELANOMA; METABOLISM; MOLECULAR DIAGNOSIS; NEVUS; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SKIN; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COHORT STUDIES; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; MALE; MELANOMA; MOLECULAR DIAGNOSTIC TECHNIQUES; NEVUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SENSITIVITY AND SPECIFICITY; SKIN; SKIN NEOPLASMS;

EID: 84865015668     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0330-OA     Document Type: Conference Paper

References (21)

1. National Cancer Institute. SEER stat fact sheets: Melanoma of the skin. http:// seer.cancer.gov/statfacts/html/melan.html. Accessed March 15, 2011.
2. Corona R, Mele A, Amini M, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol. 1996;14(4):1218-1223. (Pubitemid 26105529)
3. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol. 1996;27(6):528-531. (Pubitemid 26187274)
4. Lodha S, Saggar S, Celebi JT, Silvers DN. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting. J Cutan Pathol. 2008;35(4):349-352. (Pubitemid 351363772)
5. Shoo BA, Sagebiel RW, Kashani-Sabet M. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center. J Am Acad Dermatol. 2010;62(5):751-756.
6. Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 1998;58(10):2170-2175. (Pubitemid 28232904)
7. Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003;163(5):1765-1770. (Pubitemid 37310008)
8. Dalton SR, Gerami P, Kolaitis NA, et al. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma. Am J Surg Pathol. 2010;34(2):231-237.
9. Gerami P, Jewell SS, Morrison LE, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol. 2009;33(8):1146-1156.
10. Affymetrix. Oncoscan FFPE express services. http://www.affymetrix.com/ estore/browse/products.jsp?productId5prod150008#1-1. Accessed March 15, 2011.
11. Wang Y, Carlton VE, Karlin-Neumann G, et al. High quality copy number and genotype data from FFPE samples using molecular inversion probe (MIP) microarrays. BMC Med Genomics. 2009;2:8.
12. Wang Y, Moorhead M, Karlin-Neumann G, et al. Allele quantification using molecular inversion probes (MIP). Nucleic Acids Res. 2005;33(21):e183.
13. Wang Y, Moorhead M, Karlin-Neumann G, et al. Analysis of molecular inversion probe performance for allele copy number determination. Genome Biol. 2007;8(11):R246.
14. Nancarrow DJ, Handoko HY, Stark MS, Whiteman DC, Hayward NK. SiDCoN: A tool to aid scoring of DNA copy number changes in SNP chip data. PLoS One. 2007;2(10):e1093.
15. Gasparini R. A new FISH test for melanoma. Paper presented at: 35th Annual Association of Genetic Technologists Meeting; June 3-5, 2010; Phoenix, AZ.
16. Gammon B, Beilfuss B, Guitart J, Busam KJ, Gerami P. Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma. J Cutan Pathol. 2011;38(4):335-341.
17. Gerami P, Beilfuss B, Haghighat Z, Fang Y, Jhanwar S, Busam KJ. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi. J Cutan Pathol. 2011; 38(4):329-334.
18. Gerami P, Mafee M, Lurtsbarapa T, Guitart J, Haghighat Z, Newman M. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. Arch Dermatol. 2010;146(3):273-278.
19. Gerami P, Wass A, Mafee M, Fang Y, Pulitzer MP, Busam KJ. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Am J Surg Pathol. 2009;33(12):1783-1788.
20. Pouryazdanparast P, Newman M, Mafee M, Haghighat Z, Guitart J, Gerami P. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization. Am J Surg Pathol. 2009;33(12):1396-1400.
21. Gaiser T, Kutzner H, Palmedo G, et al. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up. Mod Pathol. 2010;23(3):413-419.